ULTRALANUM ULTRALANUM

Dose: 0.03%
Single Dose: 0.025 (0.025)
Frequency: 8 hourly
Route: Topical
Instructions:

Dose: 2.5 mg
Single Dose: 2.5 (2.5)
Frequency: 8 hourly
Route: Topical
Instructions: -

Dose: 2.5 mg
Single Dose: 2.5 (2.5)
Frequency: 8 hourly
Route: Topical
Instructions: -

belongs to Hydrocorticosterone. It belongs to Glucocorticoid agonist pharmacological group on the basis of mechanism of action and also classified in Dermatological Products pharmacological group.The Molecular Weight of Fluocortolone is 376.50.

Fluocortolone is contraindicated in conditions like Syphilis,Hypersensitivity to the drug.

The signs and symptoms that are produced after the acute overdosage of Fluocortolone include Convulsions, Respiratory arrest, Allergic skin reactions.

Fluocortolone is primarily indicated in conditions like Anal fissure, Dermatosis, Haemorrhoids, Proctitis.

No data regarding the interactions of Fluocortolone was found.

Drug should not be given to Pregnant Mothers.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Cream, Oint Protect from Sunlight.

Fluocortolone should be used with caution in patients with active tuberculosis infection of respiratory tract or in untreated fungal, bacterial or systemic viral infections. Corticosteroids should only be used systemically with great caution in the presence of congestive heart failure (CHF), recent myocardial infraction (MI), hypertension, diabetes mellitus, epilepsy, glaucoma, hypothyroidism, liver failure, osteoporosis, peptic ulceration or renal impairment. Children may be at increase risk of some adverse effects, corticosteroid causes growth retardation and prolonged use is rarely justified. Passive immunization is recommended to non-immune patients who do come in contact with chickenpox or measles. Live vaccine should not be given to patients receiving high dose systemic corticosteroid therapy nor for atleast 3 months afterwards, killed vaccine or toxoids may be given, although the response may be attenuated. During prolong treatment with corticosteroids, patients should be examined regularly, sodium intake may need to be reduced and calcium and potassium supplement may be necessary. Patient should carry cards given full details of their corticosteroid therapy. Avoid use during pregnancy.Use nasal steroids with caution until healing has occurred.